ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 29 filers reported holding ALLENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $329,000 | +64.5% | 222,381 | +75.6% | 0.00% | +50.0% |
| Q2 2020 | $200,000 | +17.6% | 126,672 | -28.3% | 0.00% | 0.0% |
| Q1 2020 | $170,000 | +0.6% | 176,774 | +325.1% | 0.00% | 0.0% |
| Q2 2019 | $169,000 | -32.4% | 41,587 | +17.0% | 0.00% | -50.0% |
| Q1 2019 | $250,000 | – | 35,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $2,518,000 | 11.16% |
| AIGH Capital Management LLC | 4,000,000 | $3,608,000 | 0.76% |
| Worth Venture Partners, LLC | 980,200 | $884,000 | 0.40% |
| Altium Capital Management LP | 1,067,886 | $963,000 | 0.25% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $3,005,000 | 0.24% |
| Golden Green, Inc. | 33,000 | $30,000 | 0.02% |
| LEVEL FOUR FINANCIAL, LLC | 40,000 | $36,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 152,731 | $138,000 | 0.01% |
| PFM Health Sciences, LP | 284,285 | $256,000 | 0.01% |
| XTX Topco Ltd | 21,443 | $19,000 | 0.01% |